- Home
- TIL vs CPHC Comparison
TIL vs CPHC Comparison
Compare TIL & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- CPHC
- Stock Information
- Founded
- TIL 2018
- CPHC 1994
- Country
- TIL United States
- CPHC United States
- Employees
- TIL N/A
- CPHC N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- CPHC Services-Misc. Amusement & Recreation
- Sector
- TIL Health Care
- CPHC Consumer Discretionary
- Exchange
- TIL Nasdaq
- CPHC Nasdaq
- Market Cap
- TIL 134.5M
- CPHC 109.9M
- IPO Year
- TIL 2021
- CPHC 1994
- Fundamental
- Price
- TIL $20.97
- CPHC $20.42
- Analyst Decision
- TIL Strong Buy
- CPHC
- Analyst Count
- TIL 4
- CPHC 0
- Target Price
- TIL $114.00
- CPHC N/A
- AVG Volume (30 Days)
- TIL 103.6K
- CPHC 2.7K
- Earning Date
- TIL 11-13-2024
- CPHC 03-10-2025
- Dividend Yield
- TIL N/A
- CPHC 1.37%
- EPS Growth
- TIL N/A
- CPHC N/A
- EPS
- TIL N/A
- CPHC 0.94
- Revenue
- TIL N/A
- CPHC $62,111,814.00
- Revenue This Year
- TIL N/A
- CPHC N/A
- Revenue Next Year
- TIL $2.65
- CPHC N/A
- P/E Ratio
- TIL N/A
- CPHC $21.69
- Revenue Growth
- TIL N/A
- CPHC 0.13
- 52 Week Low
- TIL $9.20
- CPHC $17.10
- 52 Week High
- TIL $92.00
- CPHC $30.25
- Technical
- Relative Strength Index (RSI)
- TIL 46.36
- CPHC 46.76
- Support Level
- TIL $18.56
- CPHC $20.26
- Resistance Level
- TIL $22.00
- CPHC $21.10
- Average True Range (ATR)
- TIL 1.98
- CPHC 0.60
- MACD
- TIL 0.36
- CPHC -0.09
- Stochastic Oscillator
- TIL 28.05
- CPHC 7.14
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.